Endemic and opportunistic infections in Brazilian solid organ transplant recipients

Trop Med Int Health. 2011 Sep;16(9):1134-42. doi: 10.1111/j.1365-3156.2011.02816.x. Epub 2011 Jun 21.

Abstract

Objective: To evaluate the frequency and clinical features of endemic and other opportunistic infections in liver or kidney transplant recipients in four transplant centres in different geographical areas of Brazil.

Methods: Retrospective analysis of medical and laboratory records of four transplant centres on endemic and other opportunistic infections in liver or kidney transplant recipients. Analyses were performed with spss statistical software.

Results: From 2001 to 2006, 1046 kidney and 708 liver transplants were registered in all centres. The average age was 42 years. Among 82 (4.7%) cases with infections, the most frequent was tuberculosis (2.0%), followed by systemic protozoal infections (0.7%), toxoplasmosis (0.4%) and visceral leishmaniasis (0.3%). Systemic fungal infections occurred in 0.6%, of which 0.4% were cryptococcosis and 0.2% were histoplasmosis. Dengue was the only systemic viral infection and was registered in two cases (0.1%), of which one was classified as the classic form and the other as dengue haemorrhagic fever. Nocardiosis was described in one case (0.05%). The infectious agents most frequently associated with diarrhoea were Blastocystis sp., Schistosoma mansoni and Strongyloides stercoralis.

Conclusions: Opportunistic Infections in transplant patients have a wide spectrum and may vary from asymptomatic to severe infections with high mortality. A better understanding of the epidemiology of endemic pathogens and clinical manifestations can contribute to the establishment of an early diagnosis as well as correct treatment aimed at decreasing morbidity and mortality.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Brazil / epidemiology
  • Endemic Diseases / prevention & control
  • Endemic Diseases / statistics & numerical data*
  • Female
  • Humans
  • Immunocompromised Host*
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation / adverse effects*
  • Kidney Transplantation / mortality
  • Liver Transplantation / adverse effects*
  • Liver Transplantation / mortality
  • Male
  • Opportunistic Infections / epidemiology*
  • Organ Transplantation / adverse effects*
  • Organ Transplantation / mortality
  • Postoperative Complications / epidemiology
  • Retrospective Studies

Substances

  • Immunosuppressive Agents